open access

Vol 4, No 4 (2015)
Pharmaceutical news
Published online: 2015-10-16
Get Citation

New possibilities for treatment of erectile dysfunction in men with type 2 diabetes

Roman Kuczerowski
DOI: 10.5603/DK.2015.0017
·
Diabetologia Kliniczna 2015;4(4):158-162.

open access

Vol 4, No 4 (2015)
Pharmaceutical news
Published online: 2015-10-16

Abstract

More than 50 percent of diabetes patients suffer from erectile dysfunction (ED). Sexual dysfunction may be due to metabolic, vascular, neurological, endocrine, psychological causes or be associated with side effects of pharmacotherapy. A history of erectile dysfunction should be a regular part of medical check-up. The first line treatment in majority of patients with ED are phosphodiesterase 5 (PDE5) inhibitors. The new, highly selective medicine of this group is avanafil — a drug with rapid onset of action and high efficacy in patients with diabetes.

Abstract

More than 50 percent of diabetes patients suffer from erectile dysfunction (ED). Sexual dysfunction may be due to metabolic, vascular, neurological, endocrine, psychological causes or be associated with side effects of pharmacotherapy. A history of erectile dysfunction should be a regular part of medical check-up. The first line treatment in majority of patients with ED are phosphodiesterase 5 (PDE5) inhibitors. The new, highly selective medicine of this group is avanafil — a drug with rapid onset of action and high efficacy in patients with diabetes.

Get Citation

Keywords

diabetes mellitus, erectile dysfunction, phosphodiesterase 5 inhibitor, avanafil

About this article
Title

New possibilities for treatment of erectile dysfunction in men with type 2 diabetes

Journal

Clinical Diabetology

Issue

Vol 4, No 4 (2015)

Pages

158-162

Published online

2015-10-16

DOI

10.5603/DK.2015.0017

Bibliographic record

Diabetologia Kliniczna 2015;4(4):158-162.

Keywords

diabetes mellitus
erectile dysfunction
phosphodiesterase 5 inhibitor
avanafil

Authors

Roman Kuczerowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl